Brief: Ssy Group Says NMPA Approved Passing Furosemide Injection
26/12/2024 23:57
Dec 27 (Reuters) - SSY Group 2005.HK :
* NMPA CHINA APPROVED PASSING OF CONSISTENCY EVALUATION OF
QUALITY
& EFFICACY OF GENERIC DRUGS FOR GROUP'S FUROSEMIDE INJECTION
Further company coverage: 2005.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on SSY
See all newsBrief: SSY Group Receives NMPA China Approval For Sodium Cromoglicate Eye Drops 2%
Brief: SSY Group Obtains NMPA Approval For Nimodipine Oral Solution
Brief: SSY Group Appoints Wu Heng Yao As Executive Director
Brief: SSY Group Says Ziprasidone Mesilate Receives Registration Approval In China
Hong Kong's SSY Group H1 profit rises on infusion solutions growth